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Hyperreactivity of airways to bronchoconstrictive agents
is a common feature of reactive airway diseases. In addi-
tion to its established role on vascular smooth muscle
tone, the NO/cGMP pathway is also expected to balance
the contractile responses of airway smooth muscle. The
NO-sensitive guanylyl cyclase (NO-GC) which forms
cyclic GMP in response to NO holds a key position in
this pathway and exists in two isoforms, NO-GC1 and
NO-GC2, which both have been identified in bronchial
and pulmonary blood vessels smooth muscle.
Here we determined the contribution of the NO-GC iso-
forms to the regulation of airway resistance. Airway resis-
tance was determined in a whole body plethysmography
chamber in conscious mice deficient in either NO-GC1 or
NO-GC2 in response to methacholine and serotonine inha-
lation. L-NAME was applied to NO-GC KOs to analyse the
effect mediated by the remaining NO-GC isoform and to
WT to inhibit both isoforms to see a possible synergistic or
antagonistic action. The ganglionic blocker hexamethonium
was use to differentiate bronchial and neuronal pathways.
Preliminary results indicate that both NO-GC iso-
forms contribute to airway responsiveness.
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